232
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies

, , , , , , & show all
Pages 199-210 | Accepted 28 Oct 2005, Published online: 09 Dec 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ji-Hye Byun, Sun-Hong Kwon, Ji-Eun Lee, Ji-Eun Cheon, Eun-Jin Jang & Eui-Kyung Lee. (2016) Comparison of benefit–risk preferences of patients and physicians regarding cyclooxygenase-2 inhibitors using discrete choice experiments. Patient Preference and Adherence 10, pages 641-650.
Read now

Articles from other publishers (13)

Bai-Ru Cheng, Jia-Qi Chen, Xiao-Wen Zhang, Qin-Yang Gao, Wei-Hong Li, Li-Jiao Yan, Yu-Qiao Zhang, Chang-Jiang Wu, Jing-Li Xing & Jian-Ping Liu. (2021) Cardiovascular safety of celecoxib in rheumatoid arthritis and osteoarthritis patients: A systematic review and meta-analysis. PLOS ONE 16:12, pages e0261239.
Crossref
Jean-Pierre Pelletier, Jean-Pierre Raynauld, Marc Dorais, Louis Bessette, Eva Dokoupilova, Frédéric Morin, Karel Pavelka, Patrice Paiement & Johanne Martel-Pelletier. (2020) An international, multicentre, double-blind, randomized study (DISSCO): effect of diacerein vs celecoxib on symptoms in knee osteoarthritis . Rheumatology 59:12, pages 3858-3868.
Crossref
Emma L Parry, Martin J Thomas & George Peat. (2018) Defining acute flares in knee osteoarthritis: a systematic review. BMJ Open 8:7, pages e019804.
Crossref
David S. Jevsevar, Peter B. Shores, Kyle Mullen, Danielle M. Schulte, Gregory A. Brown & Deborah S. Cummins. (2018) Mixed Treatment Comparisons for Nonsurgical Treatment of Knee Osteoarthritis: A Network Meta-analysis. Journal of the American Academy of Orthopaedic Surgeons 26:9, pages 325-336.
Crossref
Tie P. Yamato, Chris G. Maher, Bruno T. Saragiotto, Christina Abdel Shaheed, Anne M. Moseley, Chung-Wei Christine Lin, Bart Koes & Andrew J. McLachlan. (2017) Comparison of effect sizes between enriched and nonenriched trials of analgesics for chronic musculoskeletal pain: a systematic review. British Journal of Clinical Pharmacology 83:11, pages 2347-2355.
Crossref
Livia Puljak, Ana Marin, Davorka Vrdoljak, Filipa Markotic, Ana Utrobicic & Peter Tugwell. (2017) Celecoxib for osteoarthritis. Cochrane Database of Systematic Reviews 2017:7.
Crossref
Marc C Hochberg, Johanne Martel-Pelletier, Jordi Monfort, Ingrid Möller, Juan Ramón Castillo, Nigel Arden, Francis Berenbaum, Francisco J Blanco, Philip G Conaghan, Gema Doménech, Yves Henrotin, Thomas Pap, Pascal Richette, Allen Sawitzke, Patrick du Souich & Jean-Pierre Pelletier. (2016) Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Annals of the Rheumatic Diseases 75:1, pages 37-44.
Crossref
Raveendhara R. BannuruTimothy E. McAlindonMatthew C. SullivanJohn B. WongDavid M. KentChristopher H. Schmid. (2015) Effectiveness and Implications of Alternative Placebo Treatments. Annals of Internal Medicine 163:5, pages 365-372.
Crossref
Yong-Geun Park, Chul-Won Ha, Chang-Dong Han, Seong-Il Bin, Hee-Chun Kim, Young-Bok Jung & Hong-Chul Lim. (2013) A prospective, randomized, double-blind, multicenter comparative study on the safety and efficacy of Celecoxib and GCSB-5, dried extracts of six herbs, for the treatment of osteoarthritis of knee joint. Journal of Ethnopharmacology 149:3, pages 816-824.
Crossref
Paul L. McCormack. (2011) Celecoxib. Drugs 71:18, pages 2457-2489.
Crossref
S. Trijau, J. Avouac, C. Escalas, L. Gossec & M. Dougados. (2010) Influence of flare design on symptomatic efficacy of non-steroidal anti-inflammatory drugs in osteoarthritis: a meta-analysis of randomized placebo-controlled trials. Osteoarthritis and Cartilage 18:8, pages 1012-1018.
Crossref
Shaojun Shi & Ulrich Klotz. (2007) Clinical use and pharmacological properties of selective COX-2 inhibitors. European Journal of Clinical Pharmacology 64:3, pages 233-252.
Crossref
. (2006) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 15:7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.